Stock A217950 PHARMARESEARCH BIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

PHARMARESEARCH BIO Co., Ltd. Share Price

Equities

A217950

KR7217950005

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 24/06/2024 am IST 		5-day change 1st Jan Change
28,700 KRW +2.50% Intraday chart for PHARMARESEARCH BIO Co., Ltd. +2.50% +42.79%
22/02 PHARMARESEARCH BIO Co., Ltd. announced that it has received KRW 10 billion in funding from Shinhan Capital Co., Ltd. CI
19/02 PHARMARESEARCH BIO Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Shinhan Capital Co., Ltd. CI

Chart PHARMARESEARCH BIO Co., Ltd.

Dynamic Chart

Latest news about PHARMARESEARCH BIO Co., Ltd.

PHARMARESEARCH BIO Co., Ltd. announced that it has received KRW 10 billion in funding from Shinhan Capital Co., Ltd. CI
PHARMARESEARCH BIO Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Shinhan Capital Co., Ltd. CI
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd. CI
PHARMA RESEARCH BIO Co., Ltd. announced that it expects to receive KRW 30 billion in funding from PharmaResearch Co., Ltd. CI
Dongho Song cancelled the acquisition of G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd.. CI
Dongho Song agreed to acquire G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd. for KRW 5.2 billion. CI
Sangsoo Jung and others acquired 26.2% stake in Pharma Research Bio Co., Ltd. from Dong-Ho Song for KRW 16.5 billion. CI
Dong-Ho Song acquired an additional 0.034% stake in Pharma Research Bio Co., Ltd. from KDB Capital Corp.for KRW 30.5 million. CI
Dong-Ho Song acquired an additional 1.9% stake in Pharma Research Bio Co., Ltd. from KDB Capital Corp.for KRW 1.7 billion. CI
Dong-Ho Song acquired an additional 2.8% stake in Pharma Research Bio Co., Ltd. from Meritz Securities Co., Ltd, Investment Arm for KRW 2.2 billion. CI
Sangsoo Jung and others acquired 26.2% in Pharma Research Bio Co., Ltd. from Dong-Ho Song for KRW 16.5 billion. CI
BIOCND Inc. announced that it has received KRW 10 billion in funding from Pharma Research Products Co., Ltd CI
Pharma Research Products Co., Ltd completed the acquisition of 42.45% stake in BIOCND Inc. from a group of shareholders. CI
BIOCND Inc. announced that it expects to receive KRW 10 billion in funding from Pharma Research Products Co., Ltd CI
Pharma Research Products Co., Ltd signed a memorandum of understanding to acquire 42.45% stake in BIOCND Inc. from a group of shareholders for KRW 25.9 billion. CI
More news

Quotes and Performance

1 day+2.50%
1 week+2.50%
Current month+2.87%
1 month+0.53%
3 months-2.38%
6 months+38.65%
Current year+42.79%
More quotes

Highs and lows

1 week
27 500.00
Extreme 27500
28 850.00
1 month
24 050.00
Extreme 24050
29 550.00
Current year
19 610.00
Extreme 19610
32 950.00
1 year
19 050.00
Extreme 19050
32 950.00
3 years
19 020.00
Extreme 19020
45 000.00
5 years
6 170.00
Extreme 6170
45 000.00
10 years
6 170.00
Extreme 6170
45 000.00
More quotes

Managers and Directors - PHARMARESEARCH BIO Co., Ltd.

Managers TitleAgeSince
Chi-Yup Won CEO
 Chief Executive Officer 59 -
Seung-Geol Baek CEO
 Chief Executive Officer 54 -
Sang-Soo Jung CHM
 Chairman 66 -
Members of the board TitleAgeSince
Colin Francis Moorhead BRD
 Director/Board Member 58 01/22/01
Chang-Ho Kim BRD
 Director/Board Member 64 -
Sang-Soo Jung CHM
 Chairman 66 -
More insiders

Quotes

Date Price Change Volume
25/24/25 28,750 +0.17% 145
24/24/24 28,700 +2.50% 2,057
21/24/21 28,000 -0.53% 1,769
20/24/20 28,150 +0.54% 266
19/24/19 28,000 -1.58% 946

End-of-day quote Korea S.E., June 24, 2024

More quotes

Company Profile

PharmaResearch Bio Co Ltd, formerly Pharma Research Bio Co Ltd, is a Korea-based company is principally engaged in the research, development and production of biological drugs. The Company is mainly engaged in the research, development and production of botulinum toxin prescription drugs. The Company distributes its products within domestic market and to overseas markets including China and the United Kingdom.
Sector
Biotechnology & Medical Research
More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
PHARMARESEARCH BIO CO., LTD. Stock PHARMARESEARCH BIO Co., Ltd.
+42.79% 8.36Cr
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+16.45% 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+21.96% 12TCr
ARGENX SE Stock argenx SE
+25.27% 2.7TCr
BIONTECH SE Stock BioNTech SE
-20.05% 2.04TCr
BEIGENE, LTD. Stock BeiGene, Ltd.
-16.28% 1.59TCr
GENMAB A/S Stock Genmab A/S
-15.85% 1.64TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-44.35% 1.56TCr
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+63.91% 1.49TCr
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.52% 1.36TCr
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. A217950 Stock